
1. helicobacter. 2015 sep;20 suppl 1:30-5. doi: 10.1111/hel.12254.

pathogenesis gastric cancer.

figueiredo c(1)(2)(3), costa s(1), karameris a(4), machado jc(1)(2)(3).

author information: 
(1)department pathology oncology, faculty medicine university of
porto, porto, portugal.
(2)institute molecular pathology immunology university porto
(ipatimup), porto, portugal.
(3)instituto de investigação e inovação em saúde, universidade porto, porto,
portugal.
(4)department pathology, veterans administration hospital (nimts), athens,
greece.

gastric cancer (gc) fifth common malignancy third leading
cause cancer-related death worldwide. gc heterogeneous disease the
endpoint long multistep process largely influenced helicobacter pylori
infection, genetic susceptibility, environmental factors. subset gc
cases, infection epstein-barr virus (ebv) may also involved. the
development gc consequence accumulation multiple epi/genetic 
changes patient's lifetime result oncogenic activation
and/or tumor suppressor pathways' inactivation. review focus the
most recent updates characterization molecular phenotypes of
sporadic hereditary gc. article also update recent
findings relationship h. pylori infection stem cells the
origin gc. understanding molecular genetics underlying gastric
carcinogenesis paramount importance identify novel potential targets for
the development screening prognostic markers clinically
valuable management gc patients design clinical trials.

© 2015 john wiley & sons ltd.

doi: 10.1111/hel.12254 
pmid: 26372822  [indexed medline]

